SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031909
Filing Date
2024-08-14
Accepted
2024-08-14 08:45:30
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 951682
2 ex31-1.htm EX-31.1 17710
3 ex31-2.htm EX-31.2 17759
4 ex32-1.htm EX-32.1 10514
5 ex32-2.htm EX-32.2 9875
  Complete submission text file 0001493152-24-031909.txt   4692457

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sonn-20240630.xsd EX-101.SCH 39123
7 XBRL CALCULATION FILE sonn-20240630_cal.xml EX-101.CAL 38985
8 XBRL DEFINITION FILE sonn-20240630_def.xml EX-101.DEF 155521
9 XBRL LABEL FILE sonn-20240630_lab.xml EX-101.LAB 333448
10 XBRL PRESENTATION FILE sonn-20240630_pre.xml EX-101.PRE 265484
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 619123
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 241204393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)